Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Petrus Resources Announces Monthly Activity Update
-
Traction Uranium Announces Marketing Program
-
PharmaCorp Completes Acquisition of Pharmacy Files in Western Canada
-
HII’s Ingalls Shipbuilding Hosts “Signing Day” Celebrating Shipbuilder Academy Graduates
-
Trident Resources Engages Marketing Groups and Announces the Recent Exercise of 1.38M Warrants for $1.87M in Cash
-
Trident Announces Receipt of Nasdaq Determination Letter and Intent to Request Hearing
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Northrop Grumman Honors Top Suppliers Driving Industrial Innovation
-
Exodus Movement Acquires Outstanding Shares of Monavate Holdings Limited and Baanx.com Ltd.
-
FLUENT Enters into Definitive Agreement to sell Texas Business
-
CN Announces Election of Directors
-
NOVAGOLD Announces Date of Its 2026 Virtual Annual General Meeting of Shareholders
-
Guggenheim Investments Announces May 2026 Closed-End Fund Distributions
-
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Blueport Acquisition Ltd and SingAuto Inc Announce Business Combination Agreement to Create a Publicly Listed Company
-
NATURAL GAS SERVICES GROUP, INC. REPORTS FIRST QUARTER 2026 FINANCIAL AND OPERATING RESULTS
-
XMax Announces AI Model Agreement, Marking Major Milestone for its AI Business
-
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend
-
PyroGenesis Schedules 2026 First Quarter Financial Results and Business Update Conference Call
-
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
-
Xos to Showcase the Complete Commercial Electrification Ecosystem at ACT Expo 2026, From Vehicles to Mobile Energy Storage
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Ultralife Corporation to Report First Quarter Results on May 8, 2026
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Mountain Crest Acquisition 6 Corp. Announces Closing of $60 Million Initial Public Offering
-
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
-
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share
-
Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call
-
Farmer Brothers Stockholders Vote to Approve Proposed Acquisition by Royal Cup
-
Skycorp Solar Group Limited Announces Acquisition of Remaining 56% Stake in Nanjing Cesun Power Co., Ltd. and $3.0 Million Private Placement
-
Ready Capital Corporation Announces First Quarter 2026 Results and Webcast Call
-
Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q26
-
IREN Announces Successful Energization of Sweetwater 1
-
Rongcheng Group Limited Announces Entering into an Agreement and Plan of Merger with GalaxyEdge Acquisition Corporation
-
Dave & Buster’s Announces Board of Directors Transition
-
Methode Electronics to Present at the Virtual Oppenheimer Industrial Growth Conference
-
Taitron Announces Quarterly Cash Dividend
-
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
-
Heidmar Announces Filing of Its 2025 Annual Report on Form 20-F
-
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
-
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
-
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Acorn, Provider of Monitoring and Control Solutions for Generators, Cell Towers, Data Centers and other Critical Infrastructure, Hosts Q1 Earnings Call Thursday, May 7 at 11am ET
-
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
UTime Limited Announces Pricing of $1.2 Million Registered Direct Offering

